Tranexamic acid controlled release - Nordic Pharma
Alternative Names: Lysteda; Tranexamic acid SR; Tranexamic acid sustained-release; XP-12BLatest Information Update: 07 Mar 2024
At a glance
- Originator Xanodyne Pharmaceuticals
- Class Amines; Anti-infectives; Anti-inflammatories; Antifibrinolytics; Antihaemorrhagics; Cardiovascular therapies; Cyclohexanecarboxylic acids; Skin disorder therapies; Small molecules
- Mechanism of Action Antifibrinolytic agents; Plasminogen activator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menorrhagia